Venture capital is often described as the business of picking winners. Its most durable returns, however, frequently come from something more structural: recognising that a problem one industry considers solved remains unsolved somewhere else. Knowledge does not diffuse evenly across the economy. It pools inside sectors, held there by specialised vocabularies, separate conferences, distinct regulatory regimes and procurement cultures that rarely overlap. The result is a persistent set of price discrepancies in the market for ideas.

Consider the graphics processor. It was designed to render video game environments. It became the computational backbone of modern machine learning once researchers realised that parallel matrix operations were the common denominator. Or consider Great Ormond Street Hospital, which redesigned its post-surgical handovers after studying Formula 1 pit crews. In each case the underlying capability already existed. What was missing was the connective tissue between communities that seldom spoke to one another.

This is innovation arbitrage: capturing value from the gap between where a capability is mature and where it is scarce. For investors, corporate venture units and ecosystem designers, it offers a systematic alternative to chasing frontier science at frontier prices. Yet arbitrage is rarely as frictionless as the metaphor implies. Three things separate disciplined arbitrage from speculative analogy: understanding the mechanisms that enable transfer, applying frameworks that surface viable opportunities, and building the capabilities required to execute.

Cross-industry transfer rests on a simple observation. Most innovations bundle a functional principle with a domain-specific implementation. The principle is often portable: parallel computation, sterile process control, real-time sensor fusion. The implementation, with its certifications, supply chains and customer expectations, usually is not. Arbitrage begins when an investor separates the two and asks where else the principle could be reimplemented.

Three mechanisms tend to carry principles across boundaries. The first is component migration. A mature, cost-reduced input becomes cheap enough to enable applications elsewhere, as smartphone-scale production of accelerometers, cameras and batteries did for drones and wearables. The second is process transposition. Here an operational discipline travels without any physical technology at all, as lean manufacturing moved from automotive into healthcare and aviation checklists moved into surgery. The third is talent mobility, in which people carry tacit knowledge between sectors. Saxenian identified this as a defining feature of Silicon Valley's open labour markets in contrast to Route 128.

Sociologist Ronald Burt's work on structural holes explains why these mechanisms generate excess returns. Actors who bridge disconnected networks access non-redundant information, and they can broker exchanges between groups that would not otherwise trade. Andrew Hargadon and Robert Sutton documented the same dynamic at IDEO, which built its design practice on moving solutions between the many industries its clients occupied. Value accrues less to the inventor of the original idea than to whoever recognises its second home.

Critically, transfer is asymmetric. Ideas usually flow from industries with high R&D intensity, rapid iteration cycles and large consumer volumes. They flow toward sectors constrained by regulation, fragmentation or capital intensity, such as construction, agriculture, healthcare delivery and logistics. These lagging sectors are not short of problems. They are short of absorptive capacity, the term Wesley Cohen and Daniel Levinthal used for an organisation's ability to recognise, assimilate and apply external knowledge.

This asymmetry is where opportunity concentrates. The lagging sector cannot easily build the capability internally, and the leading sector often has no incentive to pursue a market it does not understand. The gap persists not because no one has noticed it, but because no single incumbent is structurally positioned to close it. That is precisely the configuration in which a venture-backed intermediary can create outsized value.

Takeaway

Arbitrage gaps persist not because they are invisible, but because no incumbent on either side of the boundary is structurally positioned to close them.

If cross-industry opportunities emerge from predictable mechanisms, they can be searched for systematically rather than stumbled upon. The most productive starting point is functional decomposition: describing a problem by the abstract job to be done rather than the industry in which it appears. A hospital managing bed occupancy, an airline managing seats and a cloud provider managing server capacity are all solving variants of the same perishable-inventory problem.

Information scientist Don Swanson demonstrated the power of this approach in the 1980s. He linked two bodies of medical literature that never cited each other, one on fish oil's effects on blood viscosity and another on the circulatory characteristics of Raynaud's syndrome. From that link he hypothesised a treatment that later clinical work supported. Swanson called this undiscovered public knowledge. Today, patent citation analysis, literature mining and large language models make it possible to run this kind of bridge-finding at scale across technical corpora.

Screening the bridges you find requires a more disciplined lens. A useful framework weighs four variables. Maturity differential asks how far ahead the source domain is in cost, reliability and tooling. Translation cost asks what must be re-engineered, re-certified or re-explained for the target. Incumbent blindness asks whether target-sector incumbents lack the technical vocabulary to recognise the solution. Value concentration asks whether the target faces a pain point acute enough to pay for adoption. The most attractive opportunities score high on differential, blindness and value, and only moderate on translation cost.

Translation cost deserves particular scrutiny because that is where most false positives hide. Many analogies feel compelling at the level of principle and collapse at the level of implementation. Recertification in medical devices or aerospace can consume years. Integration with legacy systems in utilities or banking can absorb entire funding rounds. A sound arbitrage often looks less like a breakthrough and more like a patient engineering problem with a clearly bounded scope.

Timing completes the framework. Arbitrage windows open when a source technology crosses a cost or performance threshold. They close as awareness diffuses and incumbents build internal capacity. The investor's edge therefore lies in detecting threshold crossings early, by watching component cost curves, open-source maturity and talent flows. It does not depend on predicting which frontier technology will eventually prevail.

Takeaway

Describe a problem by its abstract function rather than its industry, and the map of potential solutions expands dramatically. Most arbitrage begins with better problem definition, not better technology scouting.

Identifying an arbitrage opportunity is analytically demanding. Capturing it is organisationally harder. The defining challenge is that execution requires fluency in two domains at once, while most organisations, funds and founding teams are built around depth in one. The arbitrageur must be credible to source-domain engineers and target-domain buyers simultaneously, and those audiences rarely share standards of evidence.

The first capability is bilingual teams. Successful cross-industry ventures typically pair a founder who deeply understands the transferred technology with one who carries the scar tissue of the target industry: its procurement cycles, liability norms and unspoken assumptions about risk. Teams that over-index on technology tend to underestimate adoption friction. Teams that over-index on domain experience tend to dilute the transferred capability until it loses its edge.

The second capability is translation infrastructure. Target industries rarely buy raw technology. They buy outcomes embedded in familiar workflows, compliance documentation and service relationships. Successful ventures build the unglamorous layers, such as integration tooling, regulatory dossiers and training programmes, that convert a portable principle into an adoptable product. This is often where defensibility ultimately resides, since the underlying technology may be widely available.

For investors, execution also demands deliberate portfolio and syndicate design. Funds focused narrowly on one sector struggle to recognise opportunities arriving from outside it. Generalists may lack the networks needed to support commercialisation. Corporate venture capital can play a distinctive role here. A corporate investor from the target industry provides distribution and validation, while one from the source industry provides technical access. Josh Lerner's research suggests corporate venturing performs best when strategic fit is genuine and the parent contributes complementary assets, not merely capital.

Finally, execution requires patience calibrated to the target sector's clock speed rather than the source sector's. A machine-vision capability may iterate quarterly in consumer electronics. In agriculture, adoption follows growing seasons; in healthcare, it follows reimbursement cycles. Funds that impose source-domain timelines on target-domain markets often abandon sound arbitrage positions just before they mature.

Takeaway

The technology is often the most portable part of an arbitrage. The durable advantage lies in the translation layer that makes it legible, compliant and trustworthy to a new industry.

Innovation arbitrage shifts venture strategy away from a narrow contest over frontier science and toward a broader search for misallocated knowledge. Its premise is that the economy is full of solved problems awaiting new contexts. Those gaps persist because of structural barriers rather than informational ones.

For ecosystem designers and policymakers, the implication is that boundary-spanning infrastructure deserves as much attention as research funding. Several tools lower translation costs and enlarge the pool of potential arbitrageurs: cross-sector fellowships, shared testbeds, technology transfer offices with mandates beyond their home disciplines, and procurement programmes open to unconventional suppliers.

For investors and corporate innovation leaders, the discipline is to look sideways as rigorously as forward. The next transformative venture in a lagging industry may not require a breakthrough at all. It may only require someone fluent enough in two worlds to notice that the answer already exists.